Ela Pharma is driven to create novel therapeutics for better patient recovery and care, in the most pressing clinical applications such as organ preservation, retinal artery occlusion, acute ischemic conditions and acute liver failure.
Our proprietary technology is based on small molecules to inhibit intracellular proteolytic enzymes targeting novel anti-necrotic based pathways.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Aryeh Dulchin, 16/6,israel
- Phone
- +972 54-439-6331
- Industry
- Biotechnology
- Website
- elapharma.com
- Keywords
- Cell Necrosis, Organ Preservation, Ischemic Heart Disease, Acute Liver Failure, Brain Injury, Organ Transplant, Anti Necrosis, Necrosis Regulation, inhibiting Necrosis enzymes, Biotechnology, Biotechnology Development, Life Science, Neurodegenerative, Small Molecules, Necrosis, Inhbiting Necrosis, Inhibiting Enzymes, tissue degrading, Protease Inhibitors.
- HQ
- Tel-Aviv, Israel
Ela Pharma Ltd. Questions
Ela Pharma Ltd.'s helpline number is +972 54-439-6331
Ela Pharma Ltd.'s website is elapharma.com
Ela Pharma Ltd.'s LinkedIn profile is https://il.linkedin.com/company/ela-pharma
Ela Pharma Ltd. has
2 employees.
View email and phone details for 2
employees at Ela Pharma Ltd..
Ela Pharma Ltd.'s industry is
Biotechnology
Ela Pharma Ltd.'s top competitors are
Netagenomix,
Virucure Therapeutics,
Gna Research Ltd.,
Veeam Software,
Gammacell Bio-Technologies Ltd.,
Luthi & Co.,
Rondinx.
Ela Pharma Ltd.'s categories are Biotechnology
Ela Pharma Ltd.'s founding year is 2015
